Persistence of Cerebrospinal Fluid Oligoclonal Bands after Natalizumab Treatment of Multiple Sclerosis Patients
J.W. Stark, D. Koffler, and S.A. Sadiq. Presented at the 65th annual meeting of the American Academy of Neurology, held March 16-23, 2013 in San Diego, CA.